arrow
G

Gurvin Saini

Haukeland University Hospital
H指数:6
被引数:89

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial)

一项提前终止的2期、随机临床试验,旨在评估先前感染过SARS-CoV-2的5-11岁儿童接种mRNA疫苗BNT162b2时,单剂次与两剂次基础免疫程序在免疫原性和不良反应方面的比较(CoVacc试验)

Vaccine
IF3.5
2026-06-010
OAAI
Refining biomarker-based clustering of cardiovascular inflammatory phenotypes in HIV using Recursive Feature Addition: A comparative evaluation approach

利用递归特征添加法优化HIV患者心血管炎症表型的生物标志物聚类:一种比较评估方法

2026-04-271
OA
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic Vaccination

抗体反应在 Mpox 感染后2年得以维持,但在 Modified Vaccinia Ankara-Bavarian Nordic 疫苗接种后并未出现。

2025-09-010
OAAI
Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts

循环抗体滴度的特定阈值可预测SARS-CoV-2密切接触者的感染风险及疾病严重程度降低。

2025-05-220
OA
Associations between type III interferons, obesity and clinical severity of COVID-19

III型干扰素、肥胖与COVID-19临床严重程度之间的关系

2025-04-220
OA
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection

SARS-CoV-2疫苗后强大而持久的b细胞反应决定了对SARS-CoV-2感染的保护

2024-09-171
OAAI
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time
2023-11-029
OAAI